Lantheus Holdings (LNTH) Return on Capital Employed Growth (3y) (2018 - 2026)
Lantheus Holdings (LNTH) Return on Capital Employed Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 32.53 Bn | 30.59 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn | 480.00 |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.73 Bn | 16.42 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 1,902.00 |
| 10 | Lantheus Holdings | 6.99 Bn | 6.49 Bn | 230.92 Mn | 1,788.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,788.00 |
| Dec 31, 2025 | 1,244.00 |
| Sep 30, 2025 | -228.00 |
| Jun 30, 2025 | 1,464.00 |
| Mar 31, 2025 | 2,799.00 |
| Dec 31, 2024 | 3,370.00 |
| Sep 30, 2024 | 4,305.00 |
| Jun 30, 2024 | 3,049.00 |
| Mar 31, 2024 | 3,141.00 |
| Dec 31, 2023 | 2,659.00 |
| Sep 30, 2023 | 333.00 |
| Jun 30, 2023 | -156.00 |
| Mar 31, 2023 | -1,545.00 |
| Dec 31, 2022 | -1,152.00 |
| Sep 30, 2022 | 439.00 |
| Jun 30, 2022 | -803.00 |
| Mar 31, 2022 | -1,885.00 |
| Dec 31, 2021 | -2,494.00 |
| Sep 30, 2021 | -1,917.00 |
| Jun 30, 2021 | -1,718.00 |